Haytaian Peter D 4
4 · Elevance Health, Inc. · Filed Mar 5, 2025
Insider Transaction Report
Form 4
Haytaian Peter D
EVP & Pres Carelon & CarelonRx
Transactions
- Tax Payment
Common Stock
2025-03-03$395.50/sh−2,281$902,136→ 18,756 total - Award
Common Stock
2025-03-03+3,035→ 21,791 total - Award
Common Stock
2025-03-03+4,213→ 26,004 total - Award
Employee Stock Option (Right to Buy)
2025-03-03+11,549→ 11,549 totalExercise: $395.50Exp: 2035-03-03→ Common Stock (11,549 underlying)
Footnotes (4)
- [F1]PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
- [F2]Represents restricted share units. Restrictions lapse as follows: 1,011 shares on 3/3/2026, and 1,012 shares each on 3/3/2027 and 3/3/2028.
- [F3]Represents performance based restricted share units. Restrictions lapse on 3/3/2025.
- [F4]The option represents a right to purchase a total of 11,549 shares, and is exercisable in three annual installments, with one installment of 3,849 shares and two installments of 3,850 shares each, beginning on 3/3/2026, which is the one-year anniversary of the option grant date.